We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
Cap. Flow
+$823M
Cap. Flow %
0.99%
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$431M
2
DAL icon
Delta Air Lines
DAL
+$318M
3
DE icon
Deere & Co
DE
+$282M
4
RHI icon
Robert Half
RHI
+$270M
5
CW icon
Curtiss-Wright
CW
+$265M

Sector Composition

Rank Sector Weight
1 Financials 21.07%
2 Technology 14.6%
3 Industrials 13.72%
4 Healthcare 11.92%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRX
776
Marex Group Limited Ordinary Shares
MRX
$4.65B
-78,855
Closed -$2.46M
SVCO
777
Silvaco Group
SVCO
$262M
-23,837
Closed -$193K
PENG
778
Penguin Solutions Inc
PENG
$2.69B
-18,743
Closed -$360K
LUCK
779
Lucky Strike Entertainment
LUCK
$963M
-30,090
Closed -$301K
PRSU
780
Pursuit Attractions and Hospitality Inc
PRSU
$1.46B
-125,590
Closed -$5.34M
PFC
781
DELISTED
Premier Financial Corp. Common Stock
PFC
-29,688
Closed -$759K
SUM
782
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-46,197
Closed -$493K
OBDE
783
DELISTED
Blue Owl Capital Corporation III
OBDE
-211,895
Closed -$3.06M

Similar funds

Boston Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
  • Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
  • Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
  • Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
  • Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
  • Boston Partners opened 76 new positions and closed 81 in Q1 2025.
  • Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.

Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.